To investigate the possible mechanisms by which225Aclintuzumab may potentiate or resensitize resistant AML lines to the venetoclax, we assessed the impact of the antibody radioconjugate on cellular levels of antiapoptotic proteins MCL1, BCL2, and BCLXL
To investigate the possible mechanisms by which225Aclintuzumab may potentiate or resensitize resistant AML lines to the venetoclax, we assessed the…